journal clubs | مرکز تحقیقات غدد و متابولیسم

ردیف	تاریخ ارائه	توضیحات
1	1404/7/3	2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
2	1404/2/18	The Porphyrias Disorders of Heme Synthesis
3	1404/2/11	Guideline for the Prevention and Treatment
4	1404/1/28	HYPERTHYROHDISM
5	1404/1/21	درمان با رادیواکتیو رادیواکتیو لودین
6	1403/12/9	Onset and progression of osteoporosis
7	1403/12/23	Diabetes insipidus
8	1403/12/2	screening or not screening T1D ISPAD 2024 Recommendations
9	1403/12/16	Ramadan and Diabetes
10	1403/11/25	Insulin Resistance and Diabetes Mellitus
11	1403/11/18	Adrenal cortical carcinoma
12	1403/11/11	Management of diabetic foot ulcers
13	1403/10/27	DIABETES AND CANCER
14	1403/10/20	Management of challenging and complicated patients with DM
15	1403/10/13	Dyslipidemia management in pregnant patients: a 2024 update
16	1403/10/06	Adrenal insufficiency:identification and management
17	1403/09/29	Pheochromocytoma and paraganglioma in children
18	1403/09/01	How to manage Cushing’s disease after failed primary pituitary surgery
19	1403/08/24	Surgery of the Adrenal Glands
20	1403/08/24	Surgical Approaches to the Adrenal Gland
21	1403/08/17	Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows
22	1403/08/10	Acromegaly
23	1403/08/03	بمپدوییک اسید
24	1403/07/26	postmenopausal osteoporosis
25	1403/07/19	Late night salivary cortisol
26	1403/07/19	Salivary Cortisol test
27	1403/07/12	CKD-MBD
28	1403/07/05	Clinical Indication of FDG PET-CT in DTC
29	1403/04/14	The Genetic Testing in Endocrine Disorders
30	1403/03/31	Cyclic Cushing’s Disease
31	1403/03/20	Primary Aldosteronism Novel Approaches and Future Outlooks
32	1403/03/17	Diabetic Nephropathy
33	1403/03/10	GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
34	1403/03/03	2023 European Thyroid Association Clinical Practice Guidelines for Thyroid nodule management
35	1403/02/27	Bariatric Surgery
36	1403/02/13	Abnormal uterine bleeding in adolescents: Management
37	1403/02/06	Multimodality imaging of primary hyperparthyroidism
38	1403/01/30	Perioperative Evaluation and Management of Patients on Glucocorticoids
39	1403/01/16	Review of ICE 2024
40	1402/12/24	Management of Advanced Thyroid Cancer: Overview, Advances, and Opportunities
41	1402/12/17	Medical Nutrition Therapy IN Diabetes
42	1402/12/10	Diabetic Bladder or Diabetic Cystopathy &related complicationc
43	1402/12/03	The Revolution in Cholesterol Management: Putting REPATHA into practice
44	1402/11/26	EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
45	1402/11/12	Glucocorticoidinduced osteoporosis (GIOP)
46	1402/10/28	Thyroid Scintigraphy
47	1402/10/21	MTC
48	1402/10/14	Summary of Revisions: Standards of Medical Care in Diabetes—2024
49	1402/10/07	Summary of Revisions: Standards of Medical Care in Diabetes—2024
50	1402/09/30	OBESITY MANAGEMENT IN ADULTS
51	1402/09/23	پرولاکتینوما
52	1402/09/16	Updates on Thyroid eye disease
53	1402/09/09	Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines
54	1402/08/25	Nuclear Medicine In Diabetic Foot
55	1402/08/18	Syndrome of Inappropriate Antidiuresis
56	1402/08/11	Hypothyroidism
57	1402/08/04	Management of Osteoporosis in Postmenopausal Woman
58	1402/07/27	نحوه برخورد با شیرخوار مبتلا به ابهام جنسی
59	1402/07/21	PCOS GUIDLINE 2023
60	1402/07/13	Adrenal Incidentaloma
61	1402/07/06	Acromegaly original
62	1401/08/10	Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
63	1400/04/04	A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
64	1400/03/28	Type 1 Diabetes: Management in Women From Preconception to Postpartum
65	1400/03/21	American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool
66	1400/03/07	Vitamin D Update
67	1400/02/31	Active Surveillance of Adult Low-Risk Papillary Thyroid Carcinoma
68	1400/02/17	Management of Hypertriglyceridemia
69	1400/02/10	Adrenal Incidentaloma
70	1400/02/03	Diagnosis and Treatment of NCCAH due to 21-Hydroxylase Deficiency
71	1400/01/27	New Oral Options for Diabetic Dyslipidemia Managment
72	1400/01/20	Testosterone Deficiency in Men
73	1399/12/22	The Evolution of the Primary Aldosteronism Syndrome: Updating the Approach
74	1399/12/15	Role of Nuclear Medicine in Endocrinology
75	1399/12/08	Pituitary Disorders in Pregnancy
76	1399/12/01	IDF DaR Guideline for people with diabetes who want to fast in Ramadan
77	1399/11/24	Thyroid Eye Disease: Managing a Condition with Grave Consequences
78	1399/11/17	Dyslipidemia in Children
79	1399/11/10	Clinical Indication of FDG PET-CT in DTC
80	1399/11/03	Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes
81	1399/10/26	Practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours (NET)
82	1399/10/19	Lipid Management in Patients with Endocrine Disorders
83	1399/10/12	Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
84	1399/10/05	ADA 2021 Review
85	1399/09/28	Management of Graves‘ Thyroidal and Extrathyroidal Disease – An Update
86	1399/09/21	Approach to Managing a Postmenopausal Patient
87	1399/09/14	Endocrine Surgery during the Covid-19 pandemic
88	1399/09/07	Turner Syndrome Genome
89	1399/08/30	Glucocorticoid-Induced Osteoporosis
90	1399/08/09	Pituitary Incidentalomas
91	1399/08/02	How to use TBS in combination with BMD in clinical practice
92	1399/07/25	Glucocorticoid Induce Hyperglycemia
93	1399/07/18	Hypoparathyroidism
94	1399/07/11	Normocalcaemic Primary Hyerparathyroidism Normocalcaemic PHP
95	1399/07/04	GLP-1 AGONISTS vs SGLT2-inh ECE 2020
96	1399/03/27	PDE5 Inhibitors in Type 2 Diabetes Mellitus
97	1399/03/20	Dietary Fats and Health Outcome
98	1399/03/13	Medical Treatment with Somatostatin Analogues & Predictive Markers for Post-Surgical Medical Management of Acromegaly
99	1399/03/06	Pituitary-Tumor Endocrinopathies
100	1399/02/30	Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
101	1399/02/23	Osteoporosis in Men
102	1399/02/16	PCOS in Adolescents
103	1399/02/09	Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline
104	1399/02/02	Diabetes & Ramadan Fasting - 2020
105	1399/01/26	COVID-19 and Endocrine System
106	1399/01/20	European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
107	1398/11/29	Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
108	1398/11/15	Prolactinoma in Pregnancy and Menopause
109	1398/11/08	Nuclear Medicine & Parathyroid Diseases
110	1398/11/01	Management of Hypopituitarism
111	1398/10/24	Thermal Ablation for Papillary Thyroid Microcarcinomas
112	1398/10/17	ADA 2020 - Standards of Medical Care in diabetes
113	1398/10/10	2019European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
114	1398/10/03	Hypogonadism in Men
115	1398/09/26	Prolactinoma in Pregnancy
116	1398/09/19	Familial hypercholesterolemia in children “Diagnosis and Treatment “
117	1398/09/12	Contemporary Debates in Adult Papillary Thyroid Cancer Management
118	1398/09/05	Management Of Graves Orbitopathy
119	1398/08/28	Management of Difficult Osteoporosis
120	1398/08/21	Medical Management of Cushing’s Syndrome
121	1398/08/14	Prolactinoma
122	1398/07/30	Adrenal Crisis
123	1398/07/23	Drug Effects on the Thyroid
124	1398/07/16	Lipid
125	1398/07/09	Pheochromocytoma and Paraganglioma
126	1398/07/02	AROMATASE INHIBITORS AND BONE - ECE 2019
127	1398/03/28	Endocrine Treatment of Gender - Dysphoric/Transsexual Person
128	1398/03/21	Principles of DXA Scan Interpretation
129	1398/03/07	The Indeterminate Thyroid Nodule
130	1398/02/31	Prevention of Type 1 Diabetes
131	1398/02/24	Management of Medullary Thyroid Cancer
132	1398/02/17	Adrenal Imaging
133	1398/02/10	Osteoprosis Recumendations
134	1398/02/03	The Evaluation of Incidentally Discovered Adrenal Masses
135	1398/01/27	Update on Central Precocious Puberty: From Etiologies to Outcomes
136	1398/01/20	Treatment of Diabetes in Older Adults
137	1397/12/21	Diabetes Technology: Standards of Medical Care in Diabetes 2019
138	1397/12/14	The Management of Primary Aldosteronism Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
139	1397/12/07	Sglt2 Inhibitor
140	1397/11/30	Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
141	1397/11/23	BMD
142	1397/11/16	Thyroid and Pregnancy
143	1397/11/09	Long-term Safety & Efficacy of GH Treatment
144	1397/11/02	Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
145	1397/10/25	The Diagnosis and Management of Nonalcoholic Fatty Liver Disease
146	1397/10/18	Gaps in Guidelines for the Management of Diabetes in Low and Middle-Income Versus High-Income Countries: A Systematic Review
147	1397/10/11	RAI in low risk DTC
148	1397/10/04	Management of Hyperglycemia in Type 2 Diabetes, 2018
149	1397/09/27	Diabetic Neuropathy
150	1397/09/20	OSTEOGENESIS IMPERFECTA
151	1397/09/13	Conventional & New Treatments of Hypoparathyroidism
152	1397/09/06	CONGENITAL ADRENAL HYPERPLASIA
153	1397/08/29	ORAL SEMAGLUTIDE vs PLACEBO
154	1397/08/15	ACROMEGALY
155	1397/08/01	2018European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction
156	1397/07/24	Adrenocortical Carcinoma
157	1397/07/17	Gestational Diabetes Underpinning Principles, Surveillance, and Management
158	1397/07/10	2018European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
159	1397/07/03	Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
160	1397/03/29	Charcot Foot
161	1397/03/22	X-linked Hypophosphatemic Rickets and its Treatment with Anti-FGF23
162	1397/03/08	Differentiated Thyroid Cancer Subtypes and Prognosis
163	1397/03/01	Incidence of Bone Metastases in Differentiated Thyroid Cancer
164	1397/02/25	Ramadan Fasting & Health
165	1397/02/18	Testosterone Therapy in Men With Hypogonadism
166	1397/02/11	Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
167	1397/01/28	Acromegaly: An Endocrine Society Clinical Practice Guideline
168	1397/01/21	European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
169	1397/01/14	Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
170	1396/12/22	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Managment Algorithm-2018 Executive Summary
171	1396/12/15	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
172	1396/12/08	Some Points & Recommendations for Diagnosis Growth Hormone Deficiency in Children and Adolescents
173	1396/11/24	Definition of Pheochromocytomaand Paraganglioma (PPGL)
174	1396/11/17	Magnetic Resonance Imaging of Pituitary Tumors
175	1396/11/10	Diagnosis and Treatment PCOS
176	1396/11/03	Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline
177	1396/10/26	KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, revention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
178	1396/10/19	Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents
179	1396/10/12	Clinically Nonfunctioning Pituitary Adenomas
180	1396/10/05	Standards of Medical Care in Diabetes - 2018
181	1396/09/28	AACE FOR MANAGEMENT OF DYSLIPIDEMIA
182	1396/09/14	Pituitary Apoplexy
183	1396/09/07	Non-Classic Congenital Adrenal Hyperplasia
184	1396/08/30	Nuclear Medicine in Neuroendocrine Tumors
185	1396/08/23	Type 2 Diabetes and Osteoporosis
186	1396/08/16	The Management of Primary Aldosteronism
187	1396/08/09	Prolactinoma
188	1396/08/02	PERIPHERAL PRECOCITY
189	1396/07/25	The follicular-variant papillary thyroid cancer (FVPTC)
190	1396/07/18	Gestational Diabetes Mellitus
191	1396/07/11	Approach to the Patient with Progressive Radioiodine-Refractory Thyroid Cancer - When to Use Systemic Therapy
192	1396/07/04	Management of Graves Orbitopathy ECE2017
193	1396/03/30	Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline
194	1396/03/23	Pathogenesis and management of hypoglycemia
195	1396/03/16	Diabetes and Ramadan
196	1396/03/09	Combination Therapy in DM2
197	1396/03/02	Gastrointestinal Manifestations of Diabetes
198	1396/02/26	Ovarian Hyperthecosis
199	1396/02/19	Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study
200	1396/02/12	An update on sodium-glucose co transporter-2 inhibitors for the treatment of diabetes mellitus
201	1396/01/15	Physiological and molecular responses to bariatric
202	1395/12/17	Physical activity and exercise in children with diabetes mellitus type 1
203	1395/12/10	Pseudohypoparathyroidism, Albright’s Hereditary Osteodystrophy-Disorders Caused by Inactivating GNAS Mutations
204	1395/11/26	Management of Osteoporosis
205	1395/11/19	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
206	1395/11/12	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
207	1395/11/07	Effect of Somatostatin Analogs on the Cardiovascular System in Acromegaly
208		Thiazolidinediones Alpha and Glucosidase Inhibitors
209		Effect of Somatostatin Analogs on the Cardiovascular System in Acromegaly: A Metaanalysis
210		2016American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis part 2
211		Alcohol Ablation It’s indication, Efficacy, and Safety in Thyroid Disease
212		Central precocious puberty
213		Postoperative Management Following Pituitary Surgery
214		Diabetes and Ramadan: Practical Guidelines
215		The Increasing Incidence of Thyroid Cancer
216		EASD (2016)
217		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules
218		Achieving and Maintaining Weight Loss in Obesity: Clinical Evidence for Novel Approaches
219		European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for phaeochromocytomaor a paraganglioma
220		Approach to diabetes mellitus in children and Adolescents
221		Postmenopausal Osteoporosis
222		Diagnostic tests of cushing syndrome
223		RED CELL TRANSFUSION
224		DPP-4 inhibitors
225		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
226		Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
227		Limitation of current approaches for the treatment of acromegaly
228		COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM
229		Primary ovarian insufficiency (POI)
230		Comprehensive Type 2 Diabetes Managment Algorithm (part 2)
231		Primary Male Hypogonadism and Testosterone Therapy
232		Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
233		Timing of multiple endocrine neoplasia thyroidectomy and extent of central nacklymphadenectomy
234		Hyperglycemia Management In Patients With Post Transplantation Diabetes
235		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
236		Premature Ovarian Failure Clinical Presentation and Treatment
237		Clinical Practice Guidlines for the Diagnosis and Treatment of Postmenopausal Osteoprosis (2016)
238		Premature adrenarche
239		Diabetic Sensory and Motor Neuropathy
240		Update on subclinical thyroid dysfunction
241		Thyroid lymphoma
242		Glinids & Metformin
243		2016American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis
244		Pharmacotherapy for obesity and type 2 diabetes
245		Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR<45 <span data-scayt_word="mL" data-scaytid="146">mL/min) - Dr.Karimifard
246		Postsurgical hypoparathyroidism definitions and management
247		Standards of Medical Care in Diabetes — 2016